Skip to main content
Top
Published in: Molecular Cancer 1/2005

Open Access 01-12-2005 | Editorial

Towards Open Access

Authors: Gregory C Ippolito, Christian Schmidt, Chhaya Das, Philip W Tucker

Published in: Molecular Cancer | Issue 1/2005

Login to get access

Excerpt

The National Institutes of Health has issued a new policy for open access to all NIH-funded research, whereby NIH grantees are strongly encouraged to deposit their complete manuscripts and supplementary material to an Internet repository, thereby enabling the rapid dissemination of research results and the long-term archiving of scientific literature [1, 2]. Entitled "Policy on enhancing public access to archived publications resulting from NIH-funded research," the Public Access Policy is a major step towards the fulfillment of a universal right to access scientific information without barriers and free of charge (i.e., Open Access). The new policy derives historically from a request made by the US House Committee on Appropriations to the National Library of Medicine in 2004 to identify potential remedies to "ensure that taxpayer-funded research remains in the public domain" and to "alleviate the restrictive trend in information technology" caused by a "dramatic rise in medical research data subscription costs" [3]. …
Literature
7.
go back to reference Cozzarelli NR: Making research accessible: National Institutes of Health (NIH) public access and PNAS Open Access policies. Proc Natl Acad Sci USA. 2005, 102: 5303- 10.1073/pnas.0502201102PubMedCentralCrossRefPubMed Cozzarelli NR: Making research accessible: National Institutes of Health (NIH) public access and PNAS Open Access policies. Proc Natl Acad Sci USA. 2005, 102: 5303- 10.1073/pnas.0502201102PubMedCentralCrossRefPubMed
9.
11.
go back to reference Steinbrook R: Public access to NIH-funded research. N Engl J Med. 2005, 352: 1739-1741. 10.1056/NEJMp058088CrossRefPubMed Steinbrook R: Public access to NIH-funded research. N Engl J Med. 2005, 352: 1739-1741. 10.1056/NEJMp058088CrossRefPubMed
15.
go back to reference Cockerill MJ: Delayed impact: ISI's citation tracking choices are keeping scientists in the dark. BMC Bioinformatics. 2004, 5: 93- 10.1186/1471-2105-5-93PubMedCentralCrossRefPubMed Cockerill MJ: Delayed impact: ISI's citation tracking choices are keeping scientists in the dark. BMC Bioinformatics. 2004, 5: 93- 10.1186/1471-2105-5-93PubMedCentralCrossRefPubMed
Metadata
Title
Towards Open Access
Authors
Gregory C Ippolito
Christian Schmidt
Chhaya Das
Philip W Tucker
Publication date
01-12-2005
Publisher
BioMed Central
Published in
Molecular Cancer / Issue 1/2005
Electronic ISSN: 1476-4598
DOI
https://doi.org/10.1186/1476-4598-4-20

Other articles of this Issue 1/2005

Molecular Cancer 1/2005 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine